PFIZER (PFE.N) Trading
Live Chart & Price Analysis
View the real-time PFIZER (PFE.N) quote and decide if you want to go long or short. Find insights, analysis, the latest news and other information to help you with your trading.
Should you buy or sell PFIZER right now?
Based on NAGA Sentiment¹, 66.67% are buying PFIZER and 33.33% are selling PFIZER right now. However, opening a long or short position now depends on your risk tolerance, investment horizon, and PFIZER market outlook.
Selling
33.33%
66.67%
Buying
PFIZER price analysis
The price of PFIZER today, as of September 30, 2026, was $28.48. That's down -0.40% from last session's PFIZER closing price. The PFIZER price is rising this week. Compared to last week, the rate of PFIZER is up 1.10%, and it's down -0.80% from one month ago.
The 52-week PFIZER price high is $29.12, while the 52-week PFIZER price low is $23.53.
Year to date, PFIZER price is up 5.20% from the beginning of the year and has had a return of 5.20% in the last 12 months.
Low$28.44
Day's Range
Low$23.53
52w Range-0.8%
1h
-0.4%
24h
+1.1%
7d
+3.6%
14d
-0.8%
30d
+5.2%
1y
PFIZER trading insights
The crowd feels NEGATIVE about PFIZER, with a LOW volume of news backing the NEGATIVE sentiment score². At the start of today's PFIZER trading session, the sentiment signal³ is BEARISH, indicating whether the PFIZER price is more likely to increase or decrease today and in the following days.
The level of news⁴ backing the sentiment score is LOW, indicating how confident the markets are to buy PFIZER right now. The LOW subjectivity⁵ indicates that the PFIZER price is UNDERVALUED.
Sentiment Signal
Bearish
Next update: Oct 5, 03:25
Sentiment Score
Negative
48 / 100
Subjectivity
Low Subjectivity
-- / 100
Confidence Index
Low
Discover key PFIZER trends with NAGA Insights
What am I Missing?
Make informed decisions based on real-time data, expert analysis, and powerful research tools from TipRanks.
Access advanced PFIZER charting, technical analysis, and live market data from TradingView.
Get AI-powered PFIZER trade signals, in-depth market analysis, and technical strategy insights from Trading Central.
CFD trading involves risk
How to trade PFIZER with leverage?
Trade PFIZER if you want flexibility to speculate on its price movements in both directions. With CFDs, you can open a buy position (go long) if you think the PFIZER price will rise, or you can open a sell position (go short) if you believe the PFIZER price will fall.
You won’t need to commit to the full value of the position (see the required margin below), but bear in mind that leverage can increase both your profits and losses.
If you want to speculate on PFIZER price, search for PFIZER CFD. Then click on the "PFIZER" symbol to view the chart and other insights before placing your trade. Also, review "PFIZER" contract specification to be aware of all the PFIZER CFD trading conditions.
trading conditions:
Platform
MT5
Platform spreads
Live: 0.1505
Ticker#PFE.N
Margin (%)*
Volume step
Lot value
Minimum trade size
Maximum trade size
Commission0.00%
Monthly price change (%)0.14%
Annual price change (%)12.39%
Digits
Tick value0.009
Trading Hours & FeesCFD trading involves risk
About PFIZER
PFE
Pfizer
CFD
-0.28%
$28.65
$28.48
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
PFIZER price forecast, news, and analysis
Discover the latest news that can influence PFIZER’s earnings sentiment and PFIZER forecast and price predictions.
Positive
Pfizer's Tilrekimig Delivers Significant Skin Clearance In Phase 2 Atopic Dermatitis Study
01/10/2026/04:57
Positive
Pfizer's Tilrekimig Meets Phase 2 Primary Endpoint In Atopic Dermatitis
01/10/2026/03:25
FAQs about PFIZER trading
The price of PFIZER today, as of September 30, 2026, was 28.48. That's down -0.40% from the previous session's PFIZER closing price.
IMPORTANT NOTICE: The content presented in the instrument page is only for informational, educational and support purposes. The material presented, including analyses, sentiment, consensus, prices, opinions or other content, is not an investment recommendation or information that recommends or suggests an investment strategy, nor is it included in the scope of investment advice. NAGA will not accept liability for any loss or damage, including but not limited to any loss of profits, that may arise directly or indirectly from the use of or reliance on the information contained in this page. NAGA is not responsible for the actions or omissions of the client, especially for the acquisition or disposal of financial instruments, made based on the information contained in this page. Past performance is not necessarily indicative of future results, and anyone acting on this information does so at their own risk. ¹ NAGA sentiment reflects the positions held by active NAGA users who currently maintain open trades in a specific instrument. This information is provided for indicative purposes only and should not be interpreted as investment advice or a recommendation to trade. ² ³ ⁴ ⁵ The sentiment dashboard is provided by Trading Central. Sentiment insights and market views are based on available data and do not guarantee future performance.
Need Help? Visit our Help Section
Download NAGA Trader
Download NAGA Trader
Click the QR code to enlarge
Copyright © 2026 – All rights reserved.
NAGA is a trademark of The NAGA Group AG, a German based FinTech company publicly listed on the Frankfurt Stock Exchange | WKN: A41YCM | ISIN: DE000A41YCM0.
The website is operated by JME Financial Services (Pty) Ltd an authorised Financial Services Provider, regulated by the Financial Sector Conduct Authority in South Africa under license no. 37166. JME Financial Services (Pty) Ltd is located at Suite 10, 21 Lighthouse Rd 201 Beacon Rock, Umhlanga Rocks, Kwa-Zulu Natal, 4320, South Africa.
JME Financial Services (Pty) Ltd acts as an intermediary between the investor and NAGA Capital Ltd, the counterparty to the contract for difference purchased by the Investor via Naga.com/za. NAGA Capital Ltd is authorised and regulated by the Financial Services Authority Seychelles (FSA) under licence No. SD026. NAGA Capital Ltd is the principal to the CFD purchased by investors on this website. Other group entities: NAGA Markets Europe LTD which is authorised and regulated by the Cyprus Securities and Exchange Commission (CySEC) under licence No. 204/13.
RISK WARNING: Derivatives are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how derivatives work and whether you can afford to take the high risk of losing your money. The value of financial products can increase as well as decrease over time, depending on the value of the underlying securities and market conditions. Illustrations, forecasts or hypothetical data are not guaranteed and are provided for illustrative purposes only. JME Financial Services (Pty) Ltd does not render advice in respect of the CFD’s offered on this website. Before making an investment decision, you should rely on your own assessment. The Company’s disclaimer, conflict of interest policy are available on legal documents section.